Treatment for Teachers With Vocal Fatigue

November 16, 2023 updated by: Chayadevie Nanjundeswaran, East Tennessee State University

Cardiovascular Conditioning in the Treatment of Vocal Fatigue

Teachers are a population at high risk for voice disorders given their occupational demands. In a teaching career, a common debilitating symptom among all vocal symptoms experienced is - vocal fatigue, impacting teachers' occupational performance and increasing health care costs. It is therefore essential to identify potential treatment options to alleviate the symptom of vocal fatigue. The purpose of this study is to utilize a body-system level cardiovascular training protocol in comparison to traditional voice production training to alleviate the symptoms of vocal fatigue.

Study Overview

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Tennessee
      • Johnson City, Tennessee, United States, 37614
        • East Tennessee State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female teachers between the ages of 21-60 years Female instructors and college professors between the ages of 21-60 years
  • A score of ≥ 15 on factor 1 of the VFI (tiredness and avoidance of voice use) or a score of ≤ 5 on factor 3 of the VFI (improvement of symptoms or lack thereof with rest)
  • Sedentary- wherein participants will need to be completing mild intensity cardiovascular exercise less than 150 minutes in less than 5 days per week

Exclusion Criteria:

  • Trained athletes
  • Trained singers
  • Smoking in the past 6months
  • Prior history of a vocal fold pathology and current vocal fold pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiovascular Conditioning Protocol
Participants will complete a sub maximal cardiovascular training program twice per week for a period of 4 weeks.
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Active Comparator: Voice Production Exercises
Participants will complete voice production exercises twice per week for a period of 4 weeks.
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Physiologic Cost of Speaking
Time Frame: At baseline, at 4 weeks after treatment
Physiologic Cost of Speaking is measured as the rate of oxygen consumption at steady state/ rate of speech (wpm) for each of the two reading tasks
At baseline, at 4 weeks after treatment
Changes in Oxygen Uptake Kinetics
Time Frame: At baseline, at 4 weeks after treatment
Oxygen Uptake Kinetics is measured as the pattern of oxygen use during each of the two reading tasks
At baseline, at 4 weeks after treatment
Changes in Post Task Physiological Recovery
Time Frame: At baseline, at 4 weeks after treatment
Post Task Physiological Recovery is measured as the time, seconds, to reach baseline of oxygen consumption post task (within 0.2ml/kg/min) following each of the reading tasks
At baseline, at 4 weeks after treatment
Changes in Excess Post Exercise Consumption (EPOC)
Time Frame: At baseline, at 4 weeks after treatment
EPOC is measured as the magnitude of recovery oxygen consumption, ml/kg/min for each of the reading tasks
At baseline, at 4 weeks after treatment
Changes in Ratings of Perceived Exertion (RPE)
Time Frame: At baseline, at 4 weeks after treatment
Borg Scale of Ratings of Perceived Exertion (RPE)- measures the self-report of vocal effort for each of the reading tasks
At baseline, at 4 weeks after treatment
Changes in Vocal Fatigue Index (VFI)
Time Frame: At baseline, at 4 weeks after treatment
Vocal Fatigue Index (VFI) is a retrospective scale that measures self-reported symptoms of vocal fatigue
At baseline, at 4 weeks after treatment
Changes in Global Rating of Vocal Fatigue (VAS 100mm)
Time Frame: At baseline, at 4 weeks after treatment
Global Rating of Vocal Fatigue (VAS 100mm) measures the ability to sustain voice with no fatigue at the end of a working day
At baseline, at 4 weeks after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2020

Primary Completion (Actual)

March 30, 2023

Study Completion (Actual)

June 6, 2023

Study Registration Dates

First Submitted

July 20, 2020

First Submitted That Met QC Criteria

July 22, 2020

First Posted (Actual)

July 27, 2020

Study Record Updates

Last Update Posted (Actual)

November 18, 2023

Last Update Submitted That Met QC Criteria

November 16, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1R15DC017014-01A1 (U.S. NIH Grant/Contract)
  • 0819.1s-ETSU (Other Identifier: East Tennessee State University (ETSU))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment

Clinical Trials on Cardiovascular Conditioning Protocol

3
Subscribe